Has the use of GLP1 analogues been officially released in non-diabetic obese people?

There has been a recommendation in Brazil for the non-use of GLP1 analogues to treat obesity for over 10 years. This determination occurred because of adverse effects such as pancreatitis and...

29 June 2023 3,839 2 View